Daniel Halperin, MD

Associate Professor
University of Texas MD Anderson Cancer Center, United States

Presentation(s):

• 10: Efficacy and safety of PD-L1 (atezolizumab) and VEGF (bevacizumab) inhibition in metastatic appendiceal adenocarcinoma

  Saturday, February 17, 2024
  10:35 AM - 10:45 AM AST